Moss Genomics, Inc. (MOSS) Stock Statistics & Valuation Metrics

Moss Genomics, Inc. has a market cap or net worth of C$951.22K. The enterprise value is ―.

Moss Genomics, Inc. has 63,414,543 shares outstanding. The number of shares has decreased by -2.65% in one year.

Moss Genomics, Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Moss Genomics, Inc. is ―. Moss Genomics, Inc.’s PEG ratio is ―.

In the last 12 months, Moss Genomics, Inc. had revenue of ― and earned -133.04K in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Moss Genomics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Moss Genomics, Inc. upcoming earnings date is Nov 27, 2026, After Close (Not Confirmed).

Moss Genomics, Inc. as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Moss Genomics, Inc. has paid ― in taxes.

Moss Genomics, Inc. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Moss Genomics, Inc. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Moss Genomics, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―